Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ...
Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported first quarter 2026 U.S.
Total Revenues of $610.8 million, Cabozantinib Franchise U.S. Net Product Revenues of $555.0 million -- GAAP Diluted EPS of $0.79, Non-GAAP Diluted EPS of $0.87 -- Announced Additional Stock ...
Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside chat at the Bank of America Securities 2026 ...
Arcus outlines development strategy to establish casdatifan as a backbone therapy across each line of treatment for clear cell renal cell carcinoma (ccRCC), including the potential to become the first ...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for autoimmune and rare diseases, today ...
Bombshell lawsuits, a European safety bombshell, and a rogue Medicare program converge in the most dangerous moment in American cannabinoid policy history. WASHINGTON, DC AND CHICAGO, IL / ACCESS ...
A proactive initiative to restructure the Company’s debtA protective framework that allows for the continuation of commercial ...
FS KKR Capital Corp. faces securities fraud allegations regarding its valuation of its portfolio investments and the effectiveness of its portfolio valuation process, causing a 15% single day stock ...
Lilly’s Announced $2.3 Billion Acquisition of Ajax Validates Schrödinger’s Track Record of High-Value Collaborations NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced ...
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is ...
LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results